Anidulafungin

4 trials 1 recruiting JAnti-infectives

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

2 Completed trials

4 Sponsors

9 Countries

Phase III

Phase III: 4

Oversight events:

7 temporary halts across 1 trial

View oversight register →

Indications tested

Aspergillus infection 1 Sepsis 1 Scedosporium infection 1 Fusarium infection 1 Fungal infection 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 1 Basilea Pharmaceutica International AG Allschwil 1 Hellenic Institute For The Study Of Sepsis 1 Scynexis Inc. 1

All trials

4 total

CANDISHORT : A randomized study of a short duration therapy for candidemia Pending

2024-514244-81-00 Phase III 1 country Assistance Publique Hopitaux De Paris
A phase 3 efficacy and safety study of fosmanogepix for the treatment of adult patients with invasive mold infections Recruiting

2024-516216-16-00 Phase III 8 countries Basilea Pharmaceutica International AG Allschwil
A RANDOMIZED PROSPECTIVE CLINICAL TRIAL TO ASSESS PROCALCITONIN-GUIDANCE AND MOLECULAR-GUIDED DIAGNOSIS AS MAINSTAY FOR THERAPY OF SEVERE IN… Ended

2022-502962-26-00 Phase III 1 country Hellenic Institute For The Study Of Sepsis
Study of Two Treatment Regimens for Candidemia and/or Invasive Candidiasis: Intravenous Echinocandin followed by Oral Ibrexafungerp versus I… Ended

2024-511755-18-00 Phase III 7 countries Scynexis Inc.

Showing 1–4 of 4 trials

← All drugs A–Z